A detailed history of Aegon Asset Management Uk PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aegon Asset Management Uk PLC holds 310,976 shares of BMY stock, worth $12.3 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
310,976
Previous 367,498 15.38%
Holding current value
$12.3 Million
Previous $18.8 Million 10.51%
% of portfolio
0.25%
Previous 0.3%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$47.98 - $54.4 $2.71 Million - $3.07 Million
-56,522 Reduced 15.38%
310,976 $16.9 Million
Q4 2023

Jan 11, 2024

SELL
$48.48 - $57.85 $3.68 Million - $4.39 Million
-75,899 Reduced 17.12%
367,498 $18.8 Million
Q2 2023

Jul 28, 2023

SELL
$63.71 - $70.74 $41.8 Million - $46.4 Million
-655,371 Reduced 59.65%
443,397 $28.4 Million
Q1 2023

Apr 14, 2023

SELL
$65.71 - $74.53 $876,045 - $993,633
-13,332 Reduced 1.2%
1,098,768 $76.1 Million
Q4 2022

Oct 19, 2023

BUY
$68.48 - $81.09 $45.8 Million - $54.2 Million
668,703 Added 150.81%
1,112,100 $80 Million
Q4 2022

Jan 17, 2023

BUY
$68.48 - $81.09 $570,712 - $675,804
8,334 Added 0.76%
1,112,100 $80 Million
Q3 2022

Oct 18, 2022

BUY
$0.13 - $76.84 $36,103 - $21.3 Million
277,717 Added 33.62%
1,103,766 $78.5 Million
Q2 2022

Jul 12, 2022

BUY
$72.62 - $79.98 $60 Million - $66.1 Million
826,049 New
826,049 $63.7 Million
Q3 2020

Oct 30, 2020

SELL
$57.43 - $63.64 $3.09 Million - $3.42 Million
-53,749 Closed
0 $0
Q1 2020

Apr 30, 2020

BUY
$46.4 - $67.43 $309,488 - $449,758
6,670 Added 14.17%
53,749 $2.99 Million
Q2 2019

Jul 09, 2019

BUY
$44.62 - $49.34 $2.1 Million - $2.32 Million
47,079 New
47,079 $2.13 Million
Q4 2018

Jan 14, 2019

SELL
$48.76 - $63.23 $180,070 - $233,508
-3,693 Closed
0 $0
Q3 2018

Oct 11, 2018

BUY
$55.19 - $62.25 $203,816 - $229,889
3,693 New
3,693 $229,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Aegon Asset Management Uk PLC Portfolio

Follow Aegon Asset Management Uk PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aegon Asset Management Uk PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aegon Asset Management Uk PLC with notifications on news.